Front Matter; Therapeutic Approaches for the Treatment of Alzheimer's Disease: An Overview; Cholinesterase Inhibitors; Beyond Cholesterol: Statin Benefits in Alzheimer's Disease; PPAR . Agonists for the Treatment of Alzheimer's Disease; Metal Complexing Agents for the Treatment of Alzheimer's Disease; GSK-3 Inhibitors for the Treatment of Alzheimer's Disease; Back Matter
Summary
Alzheimer??'s disease (AD) is a neurodegenerative disease that robs the minds of our elderly population. Approximately one in every eight adults over the age of 65 and nearly half of those over 85 are afflicted with this disease. The aging population in developed societies will impose an ever increasing socioeconomic threat in the future. Current medicines for AD patients are mainly symptomatic treatments and a huge unmet medical need exists to slow the progression of this disease. A great deal of research has been dedicated to understanding the pathogenesis of AD from which comes many ideas f
